Sort
15,273 grants matching “antimicrobial resistance”
Microbial Community Disruption Following Topical Antimicrobial Application in Staphylococcus aureus-Affected Households
$775,632Stephanie Ann Fritz · Washington University · R01 · FY2025 · AI
Capacity Building and Surveillance of Antimicrobial Resistance in Indonesia
$775,370Dodi Safari · Koperasi Jasa Institut Riset Eijkman · U2G · FY2015 · GH
Antibacterial molecular coatings pre-fabricated for biologic wound dressings
$775,221Ankit Agarwal · Imbed Biosciences, Inc. · R44 · FY2014 · AR
Characterization of P. aeruginosa sRNAs that are highly expressed in human chronic infections
$775,184Marvin Whiteley · Georgia Institute Of Technology · R01 · FY2025 · AI
Bacillus subtilis Stress Responses
$775,163John D. Helmann · Cornell University · R35 · FY2021 · GM
Bacillus subtilis Stress Responses
$775,163John D. Helmann · Cornell University · R35 · FY2019 · GM
Bacillus subtilis Stress Responses
$775,163John D. Helmann · Cornell University · R35 · FY2020 · GM
The dynamics of nasal bacterial ecology and S. aureus antagonism
$775,125Lance Bradley Price · George Washington University · R01 · FY2016 · AI
Antimicrobial resistant E. coli before and after California Senate bill 27 (ARES): a natural experiment
$775,068Sara Tartof · Kaiser Foundation Research Institute · R01 · FY2018 · AI
An Expanded Multivalent Vaccine to Prevent MDR Shigella and ETEC Disease
$775,033Eileen M. Barry · University Of Maryland Baltimore · U19 · FY2020 · AI
Pro-apoptotic Drugs as Host-Directed Treatments for Pulmonary Tuberculosis
$774,881Sanjay Jain · Johns Hopkins University · R01 · FY2025 · AI
VENOUS: A translational study of enterococcal bacteremia
$774,754Cesar Augusto Arias · Methodist Hospital Research Institute · R01 · FY2023 · AI
Trial to Reduce Antimicrobial Use in Nursing home residents with Alzheimer's disease and other Dementias (TRAIN-AD)
$774,752Susan L Mitchell · Hebrew Rehabilitation Center For Aged · R37 · FY2025 · AG
Genes/Pathways for ATG Gene-dependent Inhibition of Viruses & Parasite Infection
$774,740Herbert W Virgin · Washington University · U19 · FY2014 · AI
Carbapenemase-Stable Carbapenem Antibiotics for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections
$773,298Sergei Vakulenko · University Of Notre Dame · R01 · FY2024 · AI
Carbapenemase-Stable Carbapenem Antibiotics for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections
$773,298Sergei Vakulenko · University Of Notre Dame · R01 · FY2025 · AI
Carbapenemase-Stable Carbapenem Antibiotics for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections
$773,298Sergei Vakulenko · University Of Notre Dame · R01 · FY2023 · AI
Carbapenemase-Stable Carbapenem Antibiotics for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections
$773,154Sergei Vakulenko · University Of Notre Dame · R01 · FY2022 · AI
Persistent H. influenzae in COPD - virulence, vaccines and antibiotic resistance
$772,946Timothy F Murphy · State University Of New York At Buffalo · R01 · FY2015 · AI
Targeted Clinical Trials to Reduce the Risk of Antimicrobial Resistance
$772,863Alehandro Hoberman · University Of Pittsburgh At Pittsburgh · N01 · FY2010 · AI
De Novo Synthesis, and Functional and Structural Characterization of Novel Aminoglycoside Analogues to Bypass Resistance Mechanisms and Optimize Selectivity
$772,551James E Kirby · Beth Israel Deaconess Medical Center · R01 · FY2021 · AI
Population Genomic Analysis of Gut Microbial Colonization in Premature Infants
$772,345Jillian Banfield · University Of California Berkeley · R01 · FY2023 · AI
Use of De Novo Synthesis Approaches and Structure-guided Design to Optimize Therapeutic Properties of Streptothricin Class Antimicrobials
$772,231James E Kirby · Beth Israel Deaconess Medical Center · R01 · FY2022 · AI
Genomics of S. Aureus Colonization after Initial and Recurrent Skin Infections and the Impact of Antibiotics
$771,341Michael Zdenek David · University Of Pennsylvania · R01 · FY2018 · AI
GUARD: A global unbiased antimicrobial discovery platform
$771,172Arul Jayaraman · Texas Engineering Experiment Station · R01 · FY2023 · AI